Govt’s cancer drug price curb likely to create Rs 3,357 crore savings estimate

New Delhi, November 6 (IANS): India's move to cap trade margins on 137 non-scheduled anti-cancer medicines has led 70 companies to cut maximum retail prices by an average 20 per cent to 70 per cent on 120 medicines, with estimated patient savings of Rs 3,357.49 crore, an official factsheet said on…
Read the full story on The Morung Express Opens morungexpress.com in a new tab
This is a short summary of a story published by The Morung Express, shown with a link to the original. The full story, photo and reporting belong to The Morung Express.













